Pancreatic Cancer Research

ResearcherIndian Institute of Technology MadrasActive in the last 2 years

Suresh Kumar Rayala

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0003-4394-4450; OpenAlex author ID A5069640338.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
3 (first author 0, last author 3)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Pak1 dysregulates pyruvate metabolism in PDAC cells by exerting a phosphorylation-mediated regulatory effect on PDHA1. Last author DOI 10.1016/j.jbc.2025.108409↗
  2. Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer. Last author DOI 10.1080/14728222.2016.1239719↗
  3. P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer. Last author DOI 10.1093/annonc/mdw184↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Sowmiya Murugan · 1 shared paper, 2025
  2. Sankar Jagadeeshan · 2 shared papers, 2016

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.